Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year updateAngela Dispenzieri, Soon-Chai Low, Martha Grogan et al.|Orphanet Journal of Rare Diseases|2022Cited by 91
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Márcia Waddington‐Cruz, Daniel J. Lenihan, Jonas Wixner et al.|Neurology and Therapy|2021Cited by 48
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOSJonas Wixner, Nitasha Sarswat, Angela Dispenzieri et al.|Cardiology and Therapy|2025Cited by 4
Autologous Hematopoietic Cell Transplantation in AL Amyloidosis: A Single-Center ExperienceIrene Romera, Rafael F. Duarte, J Verdejo et al.|Blood|2024Cited by 0
6108-7. BIOPSIA ENDOMIOCÁRDICA EN AMILOIDOSIS CARDIACA: EXPERIENCIA EN UN CENTRO DE REFERENCIACarlos Arellano Serrano, Javier Segovia Cubero, Juan Francisco Oteo Domínguez et al.|Revista Española de Cardiología|2025Cited by 0